RecruitingPhase 3NCT07174336A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)Sponsor: Eli Lilly and CompanyAsheville, NC · Cary, NC · Chapel Hill, NC · +126 more sites
RecruitingPhase 3NCT04852887De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)Sponsor: NRG OncologyAlbemarle, NC · Asheville, NC · +809 more sites
RecruitingPhase 3NCT06435429A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerSponsor: Jazz PharmaceuticalsAsheville, NC · Durham, NC · Morrisville, NC · +45 more sites
RecruitingPhase 3NCT05929768Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerSponsor: SWOG Cancer Research NetworkAsheboro, NC · Asheville, NC · +952 more sites